Consolidated Statement Of Shareholders' Equity - USD ($)	Total	Series K preferred OP units	Temporary Equity	Temporary Equity Series K preferred OP units	Common Stock	Additional Paid-in Capital	Distributions in Excess of Accumulated Earnings	Accumulated Other Comprehensive Income	Non-controlling Interests	Total Stockholders' Equity	Total Equity	Total Equity Series K preferred OP units
Beginning balance at Dec. 31, 2021			$ 288,900,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of third party equity interests in consolidated entities	$ 0
Issuance of stock and units						$ (200,000)			$ 2,800,000	$ 2,600,000	$ 2,600,000
Net income / (loss)			(3,100,000)
Distributions			(2,100,000)
OP Units accretion			200,000				$ (100,000)			(100,000)	100,000
Ending balance at Mar. 31, 2022			283,900,000
Beginning balance (in shares) at Dec. 31, 2021					116,000,000.0
Beginning Balance at Dec. 31, 2021					$ 1,200,000	8,175,600,000	(1,556,000,000)	$ 3,100,000	106,700,000	6,730,600,000	7,019,500,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock and units (in shares)					300,000
Issuance of stock and units						(200,000)			2,800,000	2,600,000	2,600,000
Common stock withheld to satisfy income tax obligations related to vesting of restricted stock awards (in shares)					(100,000)
Common stock withheld to satisfy income tax obligations related to vesting of restricted stock awards						(16,400,000)				(16,400,000)	(16,400,000)
Conversion of OP units						700,000			(700,000)
Share-based compensation - amortization and forfeitures						9,700,000	100,000			9,800,000	9,800,000
Other comprehensive income								22,800,000	1,100,000	23,900,000	23,900,000
Net income / (loss)	700,000						3,700,000		900,000	4,600,000	1,500,000
Distributions							(102,300,000)		(3,100,000)	(105,400,000)	(107,500,000)
OP Units accretion			200,000				(100,000)			(100,000)	100,000
Ending balance (in shares) at Mar. 31, 2022					116,200,000
Ending Balance at Mar. 31, 2022					$ 1,200,000	8,169,400,000	(1,654,600,000)	25,900,000	107,700,000	6,649,600,000	6,933,500,000
Beginning balance at Dec. 31, 2022		$ 0	202,900,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of third party equity interests in consolidated entities	(1,700,000)		1,700,000								1,700,000
Issuance of stock and units				$ 100,000,000.0					4,400,000	4,400,000	4,400,000	$ 100,000,000.0
Net income / (loss)			(4,400,000)
Distributions		(0.040)	(1,600,000)
OP Units accretion			300,000				(300,000)			(300,000)
Ending balance at Mar. 31, 2023		$ 99,900,000	298,900,000
Beginning balance (in shares) at Dec. 31, 2022					124,000,000.0
Beginning Balance at Dec. 31, 2022	7,888,500,000				$ 1,200,000	9,549,700,000	(1,731,200,000)	(9,900,000)	78,700,000	7,888,500,000	8,091,400,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock and units (in shares)					400,000
Issuance of stock and units				$ 100,000,000.0					4,400,000	4,400,000	4,400,000	$ 100,000,000.0
Common stock withheld to satisfy income tax obligations related to vesting of restricted stock awards (in shares)					(100,000)
Common stock withheld to satisfy income tax obligations related to vesting of restricted stock awards						(11,000,000.0)				(11,000,000.0)	(11,000,000.0)
Conversion of OP units (in shares)					100,000
Conversion of OP units						7,300,000				7,300,000	7,300,000
Share-based compensation - amortization and forfeitures						10,400,000				10,400,000	10,400,000
Other comprehensive income								17,600,000	600,000	18,200,000	18,200,000
Net income / (loss)	$ (30,100,000)						(27,700,000)		(800,000)	(28,500,000)	(32,900,000)
Distributions							(115,800,000)		(3,100,000)	(118,900,000)	(120,500,000)
OP Units accretion			$ 300,000				(300,000)			(300,000)
Ending balance (in shares) at Mar. 31, 2023	3,080,847				124,400,000
Ending Balance at Mar. 31, 2023	$ 7,770,100,000				$ 1,200,000	$ 9,556,400,000	$ (1,875,000,000)	$ 7,700,000	$ 79,800,000	$ 7,770,100,000	$ 8,069,000,000